Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL607399 | 1.00 | HTR2A (0.80) | HTR2ADRD3 | |
| SCHEMBL16004607 | 0.93 | HTR2A (0.80) | HTR2ADRD3 | |
| SCHEMBL607475 | 0.93 | HTR2A (0.80) | HTR2ADRD3 | |
| SCHEMBL4208408 | 0.90 | HTR2A (0.80) | HTR2ADRD3 | |
| SCHEMBL606642 | 0.90 | HTR2A (0.80) | HTR2ADRD3 | |
| SCHEMBL10164238 | 0.89 | HTR2A (1.00) | HTR2ADRD3 | |
| SCHEMBL10164205 | 0.88 | HTR2A (0.62) | HTR2ADRD3 | |
| SCHEMBL21026223 | 0.86 | HTR2A (0.82) | HTR2ADRD3 | |
| SCHEMBL607356 | 0.86 | HTR2A (1.00) | HTR2ADRD3 | |
| SCHEMBL15859546 | 0.85 | HTR2A (0.81) | HTR2ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4594294-A1 | DOPAMINE D3/D2 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-08-06 | — | — | EP | disclosed |
| WO-2024072930-A1 | DOPAMINE D3/D2 RECEPTOR PARTIAL AGONISTS FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2024-04-04 | — | — | WO | disclosed |